Trial of IW-3718 for 8 Weeks in Patients With Persistent Gastroesophageal Reflux Disease (GERD) Receiving Proton Pump Inhibitors

Condition:   Gastroesophageal Reflux Disease (GERD) Interventions:   Drug: IW-3718;   Drug: placebo Sponsor:   Ironwood Pharmaceuticals, Inc. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials